3rd. Circ. Reverses GSK Win In Avandia Marketing Suit

The Third Circuit ruled in a precedential opinion Tuesday that a Pennsylvania federal judge erred on several grounds in granting summary judgment to GlaxoSmithKline in a lawsuit over the marketing of the diabetes drug Avandia…

Read this piece in its entirety at Law360.

Comments

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s